Dr. Michael Christopher Thompson, DO

Dr. Thompson practices at Luminis Health Anne Arundel Medical Center in Annapolis, Maryland, part of Luminis Health.

Dr. Thompson's NPI, 1629462080, was assigned on March 24, 2015. Dr. Thompson holds Connecticut license 61415.

Dr. Thompson's primary practice is Luminis Health Anne Arundel Medical Center, at 2001 Medical Parkway, Annapolis, MD 21401 in Anne Arundel County. The practice phone is (443) 481-1000.

Dr. Thompson's primary practice is Luminis Health Anne Arundel Medical Center in Annapolis, Maryland, part of Luminis Health. The medical group on file is Luminis Health Maternal and Fetal Medicine Annapolis.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thompson practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Thompson's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Thompson is licensed in Connecticut.

CMS data shows 1,081 Medicare services from Dr. Thompson across 6 procedure codes in 2024, for 439 Medicare patients. Medicare paid $91,358 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 439 Medicare patients who saw Dr. Thompson in 2024. The largest group is 75 to 84, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Thompson's median patient age at 74, with 40% women.

In 2024, Dr. Thompson wrote 219 Medicare Part D claims for 113 patients. 88% of them were for generic drugs. CMS names the drug for 52 of them, across 4 drugs with 11 or more claims each, at $476 in total drug cost. In 2023, CMS named 47 claims across 3 drugs.

Dr. Thompson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Dr. Thompson from 5 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 64% of the total. Abbott Laboratories paid the most, $228.